References
- Katsaiti SM. Obesity and happiness. Applied Economics. 2012;44(31):4101–4114. doi: 10.1080/00036846.2011.587779.
- Stutzer A, Meier AN. Limited self-control, obesity, and the loss of happiness. Health Econ. 2016; 25(11):1409–1424. doi: 10.1002/hec.3227.
- Wilson PW, Anderson KM, Kannel WB. Epidemiology of diabetes mellitus in the elderly. Am J Med. 1986;80(5A):3–9. doi: 10.1016/0002-9343(86)90532-2.
- Onakpoya IJ, Heneghan CJ, Aronson JK. Post-marketing withdrawal of anti-obesity medicinal products because of adverse drug reactions: a systematic review. BMC Med. 2016; 14(1):191. doi: 10.1186/s12916-016-0735-y.
- Australian Government Department of Health and Aged Care. https://www.tga.gov.au/safety/shortages/information-about-major-medicine-shortages/about-ozempic-semaglutide-shortage-2022-and-2023. assessed on January 26
- Boye KS, Matza LS, Stewart KD, et al. Health state utilities associated with weight loss in type 2 diabetes and obesity. J Med Econ. 2022;25(1):14–25. doi: 10.1080/13696998.2021.2002062.
- Matza L, Stewart K. Redig J, et al. Health state utilities associated with weight loss: preferences of people with type 2 diabetes and obesity in Japan. J Med Econ. doi: 10.1080/13696998.2024.2316400